Brief: Bright Peak Therapeutics, Ajinomoto Enter Into Research Collaboration And License Agreement
26/03/2021 02:10
March 25 (Reuters) - Ajinomoto Co Inc 2802.T :
* BRIGHT PEAK THERAPEUTICS INC. AND AJINOMOTO CO., INC.
ENTER INTO
A RESEARCH COLLABORATION AND LICENSE AGREEMENT TO CREATE NOVEL
IMMUNOCYTOKINES
Source text for Eikon: ID:nGNE9F3CVS
Further company coverage: 2802.T
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ajinomoto Co
See all newsBrief: Ajinomoto Co Inc - Proposed To Ajinomoto (Malaysia) Berhad About Scr With Offer Price At 20.0 Ringgit Per Share, Total Capital Repayment Will Be 603.4 Million Ringgit (24.2 Billion Yen)
Pushy investors prime Japan Inc for new phase
Pushy investors prime Japan Inc for new phase
Table: Ajinomoto -2025/26 group results (IFRS)
Table: Ajinomoto -2025/26 parent results